Ken Griffin’s Citadel Places Big Short Bet Against GSK – Here’s What It Means for Investors
Ken Griffin’s Citadel hedge fund places £305M short bet against GSK, with skepticism over long-term pipeline and recent stock rally. read more
Read More
Here’s How This Macro Trader Leveraged Fed Policy for a 532% Return in 2024
In an impressive display of market acumen, trader Brent Carlile has leveraged Federal Reserve policy and interest rate changes to generate an astounding 532% return. read more
EXCLUSIVE: Ex-Rep. Kinzinger On GOP’s Internal War Over Drug Policy, Cannabis, Psychedelics – ‘Quite Likely Legal In 5-10 Years’
Adam Kinzinger predicts federal cannabis legalization and weighs in on GOP divisions over psychedelics, PTSD treatments and the future of drug reform. read more
